Xellia Pharmaceuticals testing center opens

The latest development by the Danish pharmaceutical company Xellia Pharmaceuticals has been completed at its Kõbánya site in Budapest. The laboratory constructed as part of a development of EUR 11 million will operate as a testing centre for active ingredients.

The center will also play an important role in the global operating strategy of the Danish pharmaceutical company. As a result of the expansion, more than 40 new jobs have been created so far, and through the ongoing hiring process Xellia would increase the size of the team participating in the operation of centralised laboratory services to 80 in 2019.